<?php xml version="1.0" encoding="utf-8"?>
<!-- generator="FeedCreator 1.7.2-ppt (info@mypapit.net)" -->
<feed xmlns="http://www.w3.org/2005/Atom">
    <title>Echo Pharmaceuticals BV - News</title>
    <subtitle>News updates</subtitle>
    <link rel="alternate" type="text/html" href="SITE_URL"/>
    <id>SITE_URL</id>
    <updated>2013-06-19T13:25:12+01:00</updated>
    <generator>FeedCreator 1.7.2-ppt (info@mypapit.net)</generator>
<link rel="self" type="application/atom+xml" href="http://www.echo-pharma.com/index.php/tools/packages/easy_news/rss?c=104" />
    <entry>
        <title>Time to Image</title>
        <link rel="alternate" type="text/html" href="http://www.echo-pharma.com/en/about-us/news/time-to-image/"/>
        <published>2013-06-04T13:15:00+01:00</published>
        <updated>2013-06-04T13:15:00+01:00</updated>
        <id>http://www.echo-pharma.com/en/about-us/news/time-to-image/</id>
        <author>
            <name>Oudshoorn</name>
        </author>
    </entry>
    <entry>
        <title>Symposium cannabis and elderly</title>
        <link rel="alternate" type="text/html" href="http://www.echo-pharma.com/en/about-us/news/symposium-cannabis-and-elderly/"/>
        <published>2013-02-28T14:16:00+01:00</published>
        <updated>2013-02-28T14:16:00+01:00</updated>
        <id>http://www.echo-pharma.com/en/about-us/news/symposium-cannabis-and-elderly/</id>
        <author>
            <name>Oudshoorn</name>
        </author>
    </entry>
    <entry>
        <title>Last patient included in MS trial!</title>
        <link rel="alternate" type="text/html" href="http://www.echo-pharma.com/en/about-us/news/last-patient-included-in-ms-trial/"/>
        <published>2013-01-04T14:14:00+01:00</published>
        <updated>2013-01-04T14:14:00+01:00</updated>
        <id>http://www.echo-pharma.com/en/about-us/news/last-patient-included-in-ms-trial/</id>
        <author>
            <name>Oudshoorn</name>
        </author>
    </entry>
    <entry>
        <title>First patient dosed with Namisol® in a Phase II trial in patients with chronic post-surgical abdominal pain</title>
        <link rel="alternate" type="text/html" href="http://www.echo-pharma.com/en/about-us/news/namisol-phase-ii-trial-with-patients-with-chronic-post-surgical/"/>
        <published>2012-11-19T09:03:00+01:00</published>
        <updated>2012-11-19T09:03:00+01:00</updated>
        <id>http://www.echo-pharma.com/en/about-us/news/namisol-phase-ii-trial-with-patients-with-chronic-post-surgical/</id>
        <author>
            <name>Oudshoorn</name>
        </author>
    </entry>
    <entry>
        <title>First patient dosed with Namisol® in a second phase II study in Chronic Pancreatitis</title>
        <link rel="alternate" type="text/html" href="http://www.echo-pharma.com/en/about-us/news/first-patient-dosed-with-namisol-in-a-second-phase-ii-study-in-c/"/>
        <published>2012-10-15T10:13:00+01:00</published>
        <updated>2012-10-15T10:13:00+01:00</updated>
        <id>http://www.echo-pharma.com/en/about-us/news/first-patient-dosed-with-namisol-in-a-second-phase-ii-study-in-c/</id>
        <author>
            <name>Oudshoorn</name>
        </author>
    </entry>
    <entry>
        <title>Phase I trial with Namisol® in elderly</title>
        <link rel="alternate" type="text/html" href="http://www.echo-pharma.com/en/about-us/news/phase-i-trial-with-namisol-in-elderly/"/>
        <published>2012-09-13T10:09:00+01:00</published>
        <updated>2012-09-13T10:09:00+01:00</updated>
        <id>http://www.echo-pharma.com/en/about-us/news/phase-i-trial-with-namisol-in-elderly/</id>
        <author>
            <name>Oudshoorn</name>
        </author>
    </entry>
    <entry>
        <title>Namisol® phase II study commence in pain in dementia</title>
        <link rel="alternate" type="text/html" href="http://www.echo-pharma.com/en/about-us/news/namisol-phase-ii-study-commence-in-pain-in-dementia/"/>
        <published>2012-08-02T09:59:00+01:00</published>
        <updated>2012-08-02T09:59:00+01:00</updated>
        <id>http://www.echo-pharma.com/en/about-us/news/namisol-phase-ii-study-commence-in-pain-in-dementia/</id>
        <author>
            <name>Oudshoorn</name>
        </author>
    </entry>
    <entry>
        <title>First Chronic Pancreatitis patient dosed with Namisol®</title>
        <link rel="alternate" type="text/html" href="http://www.echo-pharma.com/en/about-us/news/first-chronic-pancreatitis-patient-dosed-with-namisol/"/>
        <published>2011-10-06T13:10:00+01:00</published>
        <updated>2011-10-06T13:10:00+01:00</updated>
        <id>http://www.echo-pharma.com/en/about-us/news/first-chronic-pancreatitis-patient-dosed-with-namisol/</id>
        <author>
            <name>Oudshoorn</name>
        </author>
    </entry>
    <entry>
        <title>First Alzheimer patient dosed with Namisol®</title>
        <link rel="alternate" type="text/html" href="http://www.echo-pharma.com/en/about-us/news/first-alzheimer-patient-dosed-with-namisol/"/>
        <published>2011-09-21T12:59:00+01:00</published>
        <updated>2011-09-21T12:59:00+01:00</updated>
        <id>http://www.echo-pharma.com/en/about-us/news/first-alzheimer-patient-dosed-with-namisol/</id>
        <author>
            <name>Oudshoorn</name>
        </author>
    </entry>
    <entry>
        <title>Echo Pharmaceuticals proud sponsor of the IAMC conference in Bonn</title>
        <link rel="alternate" type="text/html" href="http://www.echo-pharma.com/en/about-us/news/echo-pharmaceuticals-proud-sponsor-of-the-iamc-conference-in-bon/"/>
        <published>2011-09-08T12:10:00+01:00</published>
        <updated>2011-09-08T12:10:00+01:00</updated>
        <id>http://www.echo-pharma.com/en/about-us/news/echo-pharmaceuticals-proud-sponsor-of-the-iamc-conference-in-bon/</id>
        <author>
            <name>Oudshoorn</name>
        </author>
    </entry>
    <entry>
        <title>First MS patient dosed with Namisol®</title>
        <link rel="alternate" type="text/html" href="http://www.echo-pharma.com/en/about-us/news/first-ms-patient-dosed-with-namisol/"/>
        <published>2011-09-01T12:03:00+01:00</published>
        <updated>2011-09-01T12:03:00+01:00</updated>
        <id>http://www.echo-pharma.com/en/about-us/news/first-ms-patient-dosed-with-namisol/</id>
        <author>
            <name>Oudshoorn</name>
        </author>
    </entry>
    <entry>
        <title>Article in ‘De Ondernemer’</title>
        <link rel="alternate" type="text/html" href="http://www.echo-pharma.com/en/about-us/news/article-in-de-ondernemer/"/>
        <published>2011-04-15T14:35:00+01:00</published>
        <updated>2011-04-15T14:35:00+01:00</updated>
        <id>http://www.echo-pharma.com/en/about-us/news/article-in-de-ondernemer/</id>
        <author>
            <name>Oudshoorn</name>
        </author>
    </entry>
    <entry>
        <title>Namisol® granted € 4.5 million</title>
        <link rel="alternate" type="text/html" href="http://www.echo-pharma.com/en/about-us/news/namisol-granted-4.5-million/"/>
        <published>2010-07-05T15:31:00+01:00</published>
        <updated>2010-07-05T15:31:00+01:00</updated>
        <id>http://www.echo-pharma.com/en/about-us/news/namisol-granted-4.5-million/</id>
        <author>
            <name>admin</name>
        </author>
    </entry>
    <entry>
        <title>Echo Pharmaceuticals secures funding</title>
        <link rel="alternate" type="text/html" href="http://www.echo-pharma.com/en/about-us/news/echo-pharmaceuticals-secures-funding/"/>
        <published>2008-01-23T15:24:00+01:00</published>
        <updated>2008-01-23T15:24:00+01:00</updated>
        <id>http://www.echo-pharma.com/en/about-us/news/echo-pharmaceuticals-secures-funding/</id>
        <author>
            <name>admin</name>
        </author>
    </entry>
    <entry>
        <title>Medicinal Cannabis (in Dutch)</title>
        <link rel="alternate" type="text/html" href="http://www.echo-pharma.com/en/about-us/news/medicinal-cannabis/"/>
        <published>2007-11-07T15:23:00+01:00</published>
        <updated>2007-11-07T15:23:00+01:00</updated>
        <id>http://www.echo-pharma.com/en/about-us/news/medicinal-cannabis/</id>
        <author>
            <name>admin</name>
        </author>
    </entry>
</feed>
